• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content

Loading…

Flash Player 9 (or above) is needed to view presentations.
We have detected that you do not have it on your computer. To install it, go here.

Like this presentation? Why not share!

Aggressive period

on

  • 1,471 views

 

Statistics

Views

Total Views
1,471
Views on SlideShare
1,471
Embed Views
0

Actions

Likes
2
Downloads
72
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Aggressive period Aggressive period Presentation Transcript

    • Prof Dr. Eman Abd El-Sattar Tella.
    • Aggressive periodontitis generally affects systemically healthy individuals less than 30 years old although patients may be older. Aggressive periodontitis may be distinguished from chronic periodontitis by the age of onset, the rapid rate of disease progression, the nature and composition of the subgingival microflora, alterations in the host's immune response and a familial aggregation of diseased individuals.
    • LOCALIZED AGGRESSIVE PERIODONTITIS Clinical Characteristics Localized aggressive periodontitis (LAP) has an age of onset around puberty. Clinically it is characterized as having "localized first molar/incisor presentation with interproximal attachment loss on at least two permanent teeth, one of which is a first molar and involving no more than two teeth other than first molars and incisors".
    • A striking feature of LAP is the lack of clinical inflammation despite the presence of deep periodontal pockets. Furthermore, the amount of plaque on the affected teeth is minimal and inconsistent with the amount of periodontal destruction present. The plaque that is present forms a thin biofilm on the teeth and rarely mineralizes to form calculus. Although the quantity of plaque may be limited, it often contains elevated levels of A actinomycetemcomitans and in some patients, Porphyromonas gingivalis.
    • - Localized aggressive periodontitis progresses rapidly. The rate of bone loss is about three to four times faster than in chronic periodontitis. - Other clinical features of LAP may include: * Distolabial migration of maxillary incisors with diastema formation. * Increasing mobility of first molars. * Sensitivity of denuded root surfaces to thermal and tactile stimuli. * Deep dull radiating pain during mastication because of irritation of the supporting structures by mobile teeth and impacted food. * Periodontal abscesses. * Regional lymph node enlargement.
    • Radiographic Findings: Vertical loss of alveolar bone around the first molars and incisors, beginning around puberty in healthy teenagers, is a classic diagnostic sign of LAP. Radiographic findings may include an "arc-shaped loss of alveolar bone extending from distal surface of second premolar to mesial surface of second molar“.
    • GENERALIZED AGGRESSIVE PERIODONTITIS Clinical Characteristics Generalized aggressive periodontitis (GAP) usually affects individuals under the age of 30 but older patients also may be affected. Clinically, GAP is characterized by "generalized interproxirnal attachment loss affecting at least three permanent teeth other than first molars and incisors". - As seen in LAP, patients with GAP have small amounts of bacterial plague associated with the affected teeth. Quantitatively, the amount of plaque seems inconsistent with the amount of periodontal destruction. Qualitatively, Porphyromonas gingivalis. A. actinomycetem- comitans and Bacteroides forsythus frequently are detected in the plaque that is present. In contrast to LAP, individuals affected with GAP produce a poor antibody response to the pathogens present.
    • The destruction occurs episodically with periods of advanced destruction followed by stages of quiescence of variable length (weeks to months or years). Radiographs show bone loss that has progressed since the previous evaluation. In cases of GAP, the gingival tissue response is a severe acutely inflamed tissue, often proliferating ulcerated and fiery red. Bleeding may occur spontaneously or with slight stimulation. Suppuration may be an important feature. This tissue response occurs in the destructive stage in which attachment and bone are actively lost.
    • In other cases, the gingival tissues may appear pink, free of inflammation. However, deep pockets can be demonstrated by probing. This tissue response coincide with periods of quiescence in which the bone level remains stationary. In other cases, the gingival tissues may appear pink, free of inflammation. However, deep pockets can be demonstrated by probing. This tissue response coincide with periods of quiescence in which the bone level remains stationary. Some patients with GAP may have systemic manifestations such as weight loss, mental depression and general malaise. They should receive medical evaluations to rule out possible systemic involvement.
    • The radiographic picture in GAP range from severe bone loss associated with minimal number of teeth to advanced bone loss affecting the majority of teeth in the dentition. Sites in GAP patients demonstrated osseous destruction of 25 to 60 % during a 9-week period. Despite this extreme loss, other sites in the same patient showed no bone loss.
    • RISK FACTORS FOR AGGRESSIVE PERIODONTITIS Microbiologic Factors - Although several specific microorganisms are detected in patients with LAP (A actinomycetemcomitans (A. a.), Capnocytophaga sp. Eikenella corrodens, Prevotella intermedia and Campyiobacter rectus), A. a. is implicated as the primary pathogen associated with this disease is based on the following evidence:
    • 1- High frequency of A. a. (approximately 90%) in lesions characteristic of LAP. 2- Elevated levels of A. a. were showed in sites with evidence of disease progression. 3- Elevated serum antibody titers to A. actinomvcetemcomitans is showed in many patients with LAP. 4- A correlation between reduction in the subgingival load of A. a. during treatment and a» successful clinical response. 5- A. a. produces a number of virulence factors that may contribute to the disease process.
    • Immunologic Factors: Some immune defects are implicated in the pathogenesis of aggressive periodontitis. The human leukocyte antigens (HLA), which regulate immune responses, were evaluated as markers for aggressive periodontitis. HLA-A9 and B15 antigens are consistently associated with aggressive periodontitis. Patients with aggressive periodontitis display functional defects of PMNs which can impair either the chemotactic attraction of PMN to the site of infection or their ability to phagocytose and kill microorganisms.
    • Genetic Factors - All individuals are not equally susceptible to aggressive periodontitis. A familial pattern of alveolar bone loss have implicated genetic factors in aggressive periodontitis. - Genetic predisposition for LAP suggest that a major gene plays a role in this disease, which is transmitted through an autosomal dominant mode of inheritance. Environmental Factors - The amount and duration of smoking can influence the extent of destruction seen in young adults.
    • TREATMENT OF AGGRESSIVE PERIODONTITIS Localized Aggressive Periodontitis - Standard periodontal therapy: Such therapy has included scaling and root planing, flap surgery with and without bone grafts, root amputations, hemisections, occlusal adjustment and strict plaque control. However, response was unpredictable. Frequent maintenance visits appear to be most important. Lack of response of aggressive periodontitis to local therapy alone is the result of the presence of A. actinomycetemcomitans in the tissues where it remains after therapy to reinfect the pocket. Systemic use of antibiotics eliminates bacteria from the tissues.
    • Current Approach to Therapy. Patients who are diagnosed as having an early form of aggressive periodontitis may respond to standard periodontal therapy. In almost all cases, systemic tetracycline (250 mg of tetracycline 4 times daily for at least 1 week) should be given in conjunction with local mechanical therapy. If surgery is indicated, systemic tetracycline should be taken approximately 1 hour before surgery. Doxycycline 100 mg/day may also be used. Chlorhexidine rinses should also be prescribed and continued for several weeks to aid healing and augment plaque control. In refractory localized aggressive periodontitis cases, tetracycline- esistant Actinobacilfus species have been suspected. After performing antibiotic susceptibility tests, the clinician may consider a combination of amoxicillin and metronidazole.